ARCHIVES

BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

FDA Continues Bureaucratic Delays Of Cancer INDs

January 30, 1976

Authorization Bill Passes Senate 82-0

June 27, 1980

Oblimersen Combination Improves CLL Survival

December 28, 2007

Congress to hold hearings on NIH ethics, Zerhouni pledges greater transparency.

January 9, 2004

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

An Adult Surgery Adapted To Children Increased Survival Of Rare Abdominal Cancer

May 28, 2010